FDA Drug information
Bosentan
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- Bosentan BOSENTAN 125 mg/1 Actavis Pharma, Inc.
- Bosentan BOSENTAN 125 mg/1 Lupin Pharmaceuticals, Inc.
- Bosentan BOSENTAN 125 mg/1 Sun Pharmaceutical Industries, Inc.
- Bosentan BOSENTAN 125 mg/1 Zydus Lifesciences Limited
- Bosentan BOSENTAN 125 mg/1 Zydus Pharmaceuticals USA Inc.
- Bosentan BOSENTAN 62.5 mg/1 Actavis Pharma, Inc.
- Bosentan BOSENTAN 62.5 mg/1 Lupin Pharmaceuticals, Inc.
- Bosentan BOSENTAN 62.5 mg/1 Sun Pharmaceutical Industries, Inc.
- Bosentan BOSENTAN 62.5 mg/1 Zydus Lifesciences Limited
- Bosentan BOSENTAN 62.5 mg/1 Zydus Pharmaceuticals USA Inc.
- Bosentan BOSENTAN ANHYDROUS 125 mg/1 Amneal Pharmaceuticals LLC
- Bosentan BOSENTAN ANHYDROUS 62.5 mg/1 Amneal Pharmaceuticals LLC
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.